drugset / Trial / NCT03586037
Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the Pharmacokinetic Interaction Between AD-2011 and AD-2012 in healthy male volunteers.
Timeline
- Start
- 2018-06-12
- Primary completion
- 2018-08-09
- Completion
- 2018-08-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ezetimibe | Unknown | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |
| Subject | Telmisartan | Other / unclassified | 80 mg | — |